7IH
LENZ

72 Investment Holdings’s LENZ Therapeutics LENZ Stock Holding History

72 Investment Holdings’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.31M Hold
1,017,751
– – 18.77% 3
2025
Q4 		$16.3M Hold
1,017,751
– – 32.2% 2
2025
Q3 		$47.4M Hold
1,017,751
– – 69.77% 1
2025
Q2 		$29.8M Hold
1,017,751
– – 77.84% 1
2025
Q1 		$26.2M Hold
1,017,751
– – 73.53% 1
2024
Q4 		$29.4M Hold
1,017,751
– – 59.83% 1
2024
Q3 		$24.2M Hold
1,017,751
– – 51.95% 1
2024
Q2 		$17.6M Hold
1,017,751
– – 44.23% 1
2024
Q1 		$22.7M Buy
+1,017,751
New +$21.2M 33.88% 2

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

72 Investment Holdings's LENZ Position: Q1 2026 in Review

72 Investment Holdings held its LENZ Therapeutics (LENZ) position steady in Q1 2026 at 1,017,751 shares worth $9.31M. The position accounts for 18.77% of the portfolio, ranked #3.

72 Investment Holdings first reported a position in LENZ in Q1 2024 and has held it in 9 quarters since. The position peaked at $47.4M in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • 72 Investment Holdings held 1,017,751 shares of LENZ Therapeutics worth $9.31M as of Q1 2026.
  • 72 Investment Holdings left its LENZ Therapeutics share count unchanged in Q1 2026.
  • LENZ Therapeutics made up 18.77% of 72 Investment Holdings's portfolio in Q1 2026, its #3 holding.
  • 72 Investment Holdings first reported a position in LENZ Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 72 Investment Holdings's LENZ Therapeutics position peaked at $47.4M in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on 72 Investment Holdings's 13F filing for Q1 2026, filed 15 May 2026.